10 March 2024>: Database Analysis
Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach
Md. Niaj Morshed 1ACEF* , Md. Rezaul Karim 12BE* , Reshmi Akter 1CDE , Safia Iqbal 1DF , Ramya Mathiyalagan 1CDF , Jong Chan Ahn 1BD , Deok Chun Yang 13CF , Joong Hyun Song 4CD , Se Chan Kang 1DFG* , Dong Uk Yang 15BFG*DOI: 10.12659/MSM.942899
Med Sci Monit 2024; 30:e942899
Figure 7 3D Interactions of Obesity-related targets-their related metabolites and control (Rosiglitazone). (A) HMOX1-10-Oxo-11-octadecenoic acid (10308378), (B) HMOX1-Rosiglitazone (77999), (C) IL18-Equol (91469), (D) IL18-Indole (798), (E) IL18-Rosiglitazone (77999), (F) TP53-Compound K (9852086), (G) TP53-Urolithin A (5488186), (H) TP53-Rosiglitazone (77999), (I) MAPK8-genipin (442424), and (J) MAPK8-Rosiglitazone (77999), (K) G6PD-Urolithin A (5488186), (L) G6PD-Rosiglitazone (77999). All the figures were generated using BIOVIA Discovery Studio Visualizer v19.1 (BIOVIA).